Ningwen Zhu

Dr. Ningwen Zhu


Research Focus & Metrics

Academic Career Length

11Years (2016-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
25 June 2021 in Tissue Engineering and Regenerative Medicine
Verified
Journal Article
Closed access
PDF file
JWJinyan Wu
Jinyan Wu
QYQuyang Yang
Quyang Yang
SWSainan Wu
Sainan Wu
RYRuoyue Yuan
Ruoyue Yuan
XZXiansheng Zhao
Xiansheng Zhao
NZNingwen Zhu
Ningwen Zhu

8 January 2016 in Journal of Translational Medicine
Verified
Journal Article
Open access
PDF file
JLJiaqi Liu
Jiaqi Liu
KSKangjie Shen
Kangjie Shen
ZFZihao Feng
Zihao Feng
YYYanhong Yang
Yanhong Yang
NZNingwen Zhu
Ningwen Zhu
FQFazhi Qi
Fazhi Qi
Histone deacetylase (HDAC) inhibitors are widely used in clinical investigation as novel drug targets. For example, panobinostat and vorinostat have been used to treat patients with melanoma. However, HDAC inhibitors are small-molecule compounds without a specific target, and their mechanism of action is unclear. Therefore, it is necessary to investigate which HDACs are required for the proliferation and metastasis of melanoma cells. We used overexpression and knocking down lentivirus to clarify the influence of HDAC5 and HDAC6 in melanoma development. Also, we introduced stable HDAC5 or HDAC6 knockdown cells into null mice and found that the knockdown cells were unable to form solid tumors. Finally, we tested HDAC5 and HDAC6 expression and sub-location in clinical melanoma tissues and tumor adjacent tissues. In this study, and found that HDAC5 and HDAC6 were highly expressed in melanoma cells but exhibited low expression levels in normal skin cells. Furthermore, we knocked down HDAC5 or HDAC6 in A375 cells and demonstrated that both HDAC5 and HDAC6 contributed to the proliferation and metastasis of melanoma cells. This study demonstrated both HDAC5 and HDAC6 were required for melanoma cell proliferation and metastasis through different signaling pathways.

9 July 2022 in Tissue Engineering and Regenerative Medicine
Verified
Journal Article
Closed access
PDF file
JWJin-Yan Wu
Jin-Yan Wu
SWSai-Nan Wu
Sai-Nan Wu
LZLi-Ping Zhang
Li-Ping Zhang
XZXian-Sheng Zhao
Xian-Sheng Zhao
YLYue Li
Yue Li
NZNingwen Zhu
Ningwen Zhu

7 March 2017 in International Journal of Molecular Medicine
Verified
Journal Article
Open access
PDF file
CSCongcong Shen
Congcong Shen
LSLinlin Sun
Linlin Sun
NZNingwen Zhu
Ningwen Zhu
FQFazhi Qi
Fazhi Qi
The commercial use of epidermal growth factor (EGF) is extensive and has been shown to be effective for skin wound healing in clinical practice. There is evidence to indicate that the topical administration of EGF significantly accelerates re-epithelialization by promoting keratinocyte mitogenesis and migration following acute injury; however, the mechanisms involved remain to be elucidated. Thus, in this study, we focused on Kindlin-1, a four-point-one, ezrin, radixin, moesin (FERM)-domain-containing adaptor protein, and report its contribution to EGF-induced re-epithelialization in skin wound healing. In tissue samples, the expression of Kindlin-1 was induced upon EGF treatment compared to that in the natural healing group. In immortalized human keratinocytes (HaCaT cells), we further proved that Kindlin-1 was necessary for mediating EGF-induced activation signals, including integrin β1 activation, focal adhesion kinase (FAK) phosphorylation and actin re-organization, which finally led to enhanced cell proliferation and migration. These results indicate that Kindlin-1 is essential in EGF-induced re-epithelialization in skin wound healing and provide additional rationale for the clinical application of EGF in the treatment of acute wounds.

20 June 2025 in Biomaterials
Verified
Journal Article
Closed access
ZZZe-Ming Zhuang
Ze-Ming Zhuang
YWYong Wang
Yong Wang
LCLi Chen
Li Chen
ZWZhang-Rui Wu
Zhang-Rui Wu
TZTao Zhang
Tao Zhang
WTWei-Qiang Tan
Wei-Qiang Tan

12 April 2023 in Applied Nanoscience
Verified
Journal Article
Closed access
PDF file
QYQuyang Yang
Quyang Yang
YLYue Li
Yue Li
XZXiansheng Zhao
Xiansheng Zhao
JZJin Zhang
Jin Zhang
XCXiujun Cheng
Xiujun Cheng
NZNingwen Zhu
Ningwen Zhu